InvestorsHub Logo
Followers 8
Posts 105
Boards Moderated 0
Alias Born 12/02/2023

Re: tootalljones post# 453537

Wednesday, 03/06/2024 9:40:38 AM

Wednesday, March 06, 2024 9:40:38 AM

Post# of 459967
If as you say their drug candidate is no good can you say which are the "good" AD drugs patients should be having instead?

Dr Marwan Sabbagh clearly wasn't hired for RETT. He said the following: "I’m excited to join Anavex’s Scientific Advisory Board at this time of important progress of the Company. There is such a significant unmet medical need around the globe caused by Alzheimer’s disease and given the robust clinical data of blarcamesine (ANAVEX®2-73) in Alzheimer’s disease I look forward to joining the scientific team at Anavex to move forward a path for patients and their loved ones to be able to provide an effective therapeutic which can be taken orally and is generally safe.”
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News